Philip Morris International Inc · NYSE:PM
Philip Morris International — Investor Day (September 2023)
5 slides from Philip Morris International's investor day presentation, Sep 28, 2023
Slide 1: Championing a Smoke-Free World
Championing a Smoke-Free World Matthew R. Holman, Ph.D. Vice President & Chief Science & Regulatory Strategy Officer, U.S(a) September 28, 2023 (a) Office of Science Director at FDA’s Center for Tobacco Products (2017-2022) Forward-Looking and Cautionary Statements • This presentation contains proje
Slide 2: Heated Tobacco Products Applications
Glossary and Key Terms and Definitions • A glossary of terms, including the definition for smoke-free products as well as adjustments, other calculations and reconciliations to the most directly comparable U.S. GAAP measures for non-GAAP financial measures cited in this presentation are available on
Slide 3: Swedish Snus – First MRTP Authorized by FDA
Swedish Snus –First MRTP Authorized by FDA • General Snus MRTPA renewal submitted in July: ⎼ Tobacco, mint, & wintergreen flavors ⎼ MRTPA claim: “Using General Snus instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.”
Slide 4: PMTA Authorizations and MRTPA Authorizations
PMTA Authorizations 16 of 45 Authorizations (36%) 7 MRTPA Authorizations 13 of 16 Authorizations (81%) 8
Slide 5: Overcoming Regulatory Challenges
Overcoming Regulatory Challenges • Substantial PMTA backlog: ⎼ Long queue ⎼ Unpredictable timing • PMI is developing innovative products: ⎼ Example: IQOS ILUMA converts more smokers than IQOS 3.0 • Confident of success with authorizations: ⎼ Submitting robust data on ‘appropriate for protection of p
Philip Morris International — Investor Day (September 2023) on 6ix